temanogrel oral (APD791 oral) / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
temanogrel oral (APD791 oral) / Pfizer
NCT00619931: A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

Completed
1
50
US
APD791
Arena Pharmaceuticals
Healthy
06/08
06/08
NCT00529646: Single-Dose Safety Study of APD791 in Healthy Volunteers

Completed
1
90
US
APD791
Arena Pharmaceuticals
Healthy
 
 
NCT02034292: Safety Study of APD-791 With Aspirin and/or Clopidogrel

Terminated
1
16
NA
Clopidogrel, Aspirin, APD791, Placebo
IlDong Pharmaceutical Co Ltd, Asan Medical Center
Acute Coronary Syndrome
03/14
03/14
NCT02419820: Dose-escalation, Repeated and Single Oral Dosing Study

Terminated
1
104
NA
APD791, Temanogrel, Clopidogrel, Plavix, Aspirin, Aspirin Protect, Placebo for APD791, Placebo for Temanogrel
IlDong Pharmaceutical Co Ltd, Asan Medical Center
Acute Coronary Syndrome
04/16
04/16

Download Options